This pathway is already familiar because several approved diabetes and weight-management medicines act on GLP-1 receptors
Limitations: As with all GLP-1 therapies, ongoing monitoring for gastrointestinal side effects and potential hypoglycemia (especially in combination with a sulfonylurea) remains crucial
Set reminders if you need to
Patients should seek urgent evaluation for new or worsening weakness, trouble walking, new neurological deficits, severe confusion, chest pain, shortness of breath, fainting, severe anemia symptoms, bowel or bladder dysfunction, saddle anesthesia, fever, unexplained weight loss, rapidly worsening numbness, or rapidly worsening symptoms
Food and Drug Administration formally declared the semaglutide injection shortage resolved. In the months that followed, the FDA also confirmed the resolution of tirzepatide injection shortages and clarified post-shortage compounding expectations., Despite this, online advertisements continue to promote compounded GLP-1 medications
If you havent explored mobility aids for senior dogs, those small environmental changes can also reduce daily strain on damaged joints
